Emerging therapies targeting tumor vasculature in multiple myeloma and other hematologic and solid malignancies. [electronic resource]
Producer: 20120816Description: 1005-24 p. digitalISSN:- 1873-5576
- Angiogenesis Inhibitors -- pharmacology
- Antibodies, Monoclonal -- therapeutic use
- Benzenesulfonates -- pharmacology
- Hematologic Neoplasms -- drug therapy
- Humans
- Indoles -- pharmacology
- Multiple Myeloma -- blood supply
- Neovascularization, Pathologic -- drug therapy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Phthalazines -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyridines -- pharmacology
- Pyrroles -- pharmacology
- Receptors, Vascular Endothelial Growth Factor -- metabolism
- Signal Transduction
- Sorafenib
- Sunitinib
- Thalidomide -- pharmacology
- Vascular Endothelial Growth Factor A -- metabolism
- Wnt Signaling Pathway
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.